World's Best Scientists 2026 revealed!
Inflammatory Bowel Diseases
H-index 42

Inflammatory Bowel Diseases

1078-0998

Published by: Oxford University Press

https://academic.oup.com/ibdjournal

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Immunology 77 73 129 21
Medicine 378 298 715 40

Additional Metrics

Number of Best Scientists*: 609
Documents by Best Scientists*: 971
Top 100 Ranked Scientists*: 23
SCIMAGO H-index: 183
SCIMAGO SJR: 1.78
Impact Factor: 4.3

Overview

Top Research Topics at Inflammatory Bowel Diseases?

The journal facilitates discussions on Internal medicine, Inflammatory bowel disease, Gastroenterology, Crohn's disease and Ulcerative colitis. Inflammatory Bowel Diseases discusses concepts in Disease, Colitis and Infliximab under Internal medicine and how they intertwine with disciplines like In patient. The study on Infliximab presented in Inflammatory Bowel Diseases intersects with subjects under the field of Adalimumab.

While work presented in the journal provided substantial information on Inflammatory bowel disease, it also covered topics in Odds ratio, Immunology, Intensive care medicine, Prospective cohort study and Cohort. It encompasses presentations on Immunology, specifically Inflammation, Immune system, Cytokine, Tumor necrosis factor alpha and Proinflammatory cytokine. Colonoscopy, Azathioprine and Calprotectin are some topics wherein Gastroenterology research discussed in the journal have an impact.

It tackles topics on Crohn's disease, which can potentially contribute to the wider field of Pathology. Colectomy is the primary subject of Ulcerative colitis works presented in the journal.

  • Internal medicine (46.74%)
  • Inflammatory bowel disease (40.37%)
  • Gastroenterology (31.37%)

What are the most cited papers published in the journal?

  • A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. (1029 citations)
  • Long-term evolution of disease behavior of Crohn's disease. (1026 citations)
  • Low counts of Faecalibacterium prausnitzii in colitis microbiota. (883 citations)

Research areas of the most cited articles at Inflammatory Bowel Diseases:

The most cited publications aim to foster the development of research in Inflammatory bowel disease, Internal medicine, Crohn's disease, Ulcerative colitis and Gastroenterology. The published articles explore topics in Inflammatory bowel disease which can be helpful for research in disciplines like Odds ratio, Physical therapy and Colitis, Immunology. The published papers dive deep in exploring the relationship between the study of Internal medicine and Surgery.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Disease
  • Gene

The previous edition focused in particular on these issues:

Inflammatory Bowel Diseases explores disciplines such as Internal medicine, Inflammatory bowel disease, Ulcerative colitis, Gastroenterology and Crohn's disease. Odds ratio, Cohort, Hazard ratio, Confidence interval and Ustekinumab are some of the facets of Internal medicine tackled in Inflammatory Bowel Diseases. The featured Inflammatory bowel disease study falls within the wider topic of Disease.

The Ulcerative colitis works featured in it incorporate elements from Dermatology, Adverse effect and Tofacitinib. The subject of MEDLINE, which is connected to the field of Text mining, serves as the foundation of the Gastroenterology research featured in Inflammatory Bowel Diseases. It focuses on Crohn's disease research which is adjacent to topics in Surgery.

The most cited articles from the last journal are:

  • The SPOSIB SB2 Sicilian Cohort: Safety and Effectiveness of Infliximab Biosimilar SB2 in Inflammatory Bowel Diseases, Including Multiple Switches (18 citations)
  • Characteristics and Outcomes of IBD Patients with COVID-19 on Tofacitinib Therapy in the SECURE-IBD Registry. (15 citations)
  • Multidimensional Impact of Mediterranean Diet on IBD Patients. (15 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Inflammatory Bowel Diseases (based on the number of publications) are:

  • William J. Sandborn (212 papers) published 13 papers at the last edition, 10 more than at the previous edition,
  • Edward V. Loftus (137 papers) published 3 papers at the last edition, 2 more than at the previous edition,
  • Bo Shen (123 papers) published 4 papers at the last edition,
  • Marie L. Borum (122 papers) absent at the last edition,
  • Jean-Frederic Colombel (106 papers) published 7 papers at the last edition, 4 more than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Inflammatory Bowel Diseases (based on the number of publications) are:

  • Mayo Clinic (337 papers) published 26 papers at the last edition, 16 more than at the previous edition,
  • Boston Children's Hospital (322 papers) published 20 papers at the last edition, 2 more than at the previous edition,
  • Harvard University (299 papers) published 14 papers at the last edition the same number as at the previous edition,
  • Cleveland Clinic (241 papers) published 20 papers at the last edition, 8 more than at the previous edition,
  • University of Chicago (237 papers) published 13 papers at the last edition, 7 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 7.92% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 31.70% were posted by at least one author from the top 10 institutions publishing in the journal. Another 10.32% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 13.51% of all publications and 44.47% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Top Publications

  • The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn’s & Colitis Foundation

    K T Park;Orna G Ehrlich;John I Allen;Perry Meadows

    (2020)
    386 Citations
  • Very Early Onset Inflammatory Bowel Disease: A Clinical Approach With a Focus on the Role of Genetics and Underlying Immune Deficiencies

    Jodie Ouahed;Elizabeth Spencer;Daniel Kotlarz;Dror S Shouval

    (2020)
    202 Citations
  • Expression of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in the Gut of Patients With IBD.

    Juan F Burgueño;Adrian Reich;Hajar Hazime;Maria A Quintero

    (2020)
    162 Citations
  • Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID

    (2021)
    145 Citations
  • Enteroendocrine Cells: Sensing Gut Microbiota and Regulating Inflammatory Bowel Diseases

    Yanbo Yu;Wenjing Yang;Yanqing Li;Yingzi Cong

    (2020)
    101 Citations
  • Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of Results from Phase 2/3 Studies

    William J Sandborn;Brian G Feagan;Silvio Danese;Christopher D O'Brien

    (2021)
    89 Citations
  • The Relationship Between Symptoms of Depression and Anxiety and Disease Activity in IBD Over Time.

    Ruth Ann Marrie;Lesley A Graff;John D Fisk;Scott B Patten

    (2021)
    86 Citations
  • Dashboard-Driven Accelerated Infliximab Induction Dosing Increases Infliximab Durability and Reduces Immunogenicity.

    (2022)
    85 Citations
  • Capsule Retention in Crohn's Disease: A Meta-analysis

    Shabana F Pasha;Marco Pennazio;Emanuele Rondonotti;Douglas Wolf

    (2020)
    74 Citations

Related Online Degrees & Career Pathways

For those interested in expanding their medical knowledge beyond studying Medicine in the USA, various online nursing degrees offer flexible pathways into healthcare careers. Programs like adn to np programs allow registered nurses to advance to nurse practitioner roles efficiently, bridging associate degrees to master's qualifications.

Alternatively, individuals without a nursing background can explore online direct entry msn programs for non-nurses. These accelerated degrees provide a pathway into nursing leadership and specialized clinical positions, opening doors to a rewarding healthcare career.

For those holding an RN license seeking to enhance their bachelor's degree, comparing options such as capella university vs wgu rn to bsn programs helps identify flexible and reputable institutions focused on career growth.

Cost-effective options are also available for students wanting to pursue advanced degrees without financial strain. Exploring the online bsn programs can reveal affordable pathways for registered nurses aiming to earn both bachelor’s and master’s degrees online.

Best Scientists Contributing to This Journal

Recently Published Articles